Dry and liquid formulations of IBT-V02, a novel multi-component toxoid vaccine, are effective against Staphylococcus aureus isolates from low-to-middle income countries
Article in Frontiers in Immunology (April 2024)
The most recent citing publications are shown below. View all 3 publications that cite this research output on Dimensions.
Article in Frontiers in Immunology (April 2024)
Article in Biomolecules (February 2024)
Article in Journal of Basic Microbiology (February 2024)